These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 7542451

  • 1. Actions of 3,5,3'-tri-iodothyronine on the synthesis and secretion of major plasma proteins by a human hepatoblastoma cell line (Hep G2).
    Kobayashi M, Horiuchi R.
    J Mol Endocrinol; 1995 Apr; 14(2):227-35. PubMed ID: 7542451
    [Abstract] [Full Text] [Related]

  • 2. Dualistic effects of thyroid hormone on a human hepatoma cell line: inhibition of thyroxine-binding globulin synthesis and stimulation of alpha 1-acid glycoprotein synthesis.
    Kobayashi M, Horiuchi R, Hachisu T, Takikawa H.
    Endocrinology; 1988 Jul; 123(1):631-40. PubMed ID: 2838266
    [Abstract] [Full Text] [Related]

  • 3. Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells.
    Bartalena L, Farsetti A, Flink IL, Robbins J.
    Mol Endocrinol; 1992 Jun; 6(6):935-42. PubMed ID: 1323058
    [Abstract] [Full Text] [Related]

  • 4. Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2).
    Jin FY, Kamanna VS, Chuang MY, Morgan K, Kashyap ML.
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1052-62. PubMed ID: 8696946
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of thyroxine-binding globulin messenger ribonucleic acid by 3,5,3'-triiodothyronine in human hepatoblastoma cells.
    Crowe TC, Cowen NL, Loidl NM, Topliss DJ, Stockigt JR, Barlow JW.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2233-7. PubMed ID: 7608285
    [Abstract] [Full Text] [Related]

  • 6. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
    Chung IH, Chen CY, Lin YH, Chi HC, Huang YH, Tai PJ, Liao CJ, Tsai CY, Lin SL, Wu MH, Chen CY, Lin KH.
    Oncotarget; 2015 Jun 20; 6(17):15050-64. PubMed ID: 25940797
    [Abstract] [Full Text] [Related]

  • 7. Multihormonal control of cell proliferation: opposite effects of two stimulators (17 beta-estradiol and L-triiodothyronine) and one inhibitor (dexamethasone) on F4Z2 pituitary tumor cells.
    Zhou-Li F, Joly-Pharaboz MO, Bouillard B, Albaladejo V, Nicolas B, Andre J.
    Endocrinology; 1991 Jun 20; 128(6):2761-8. PubMed ID: 2036960
    [Abstract] [Full Text] [Related]

  • 8. Phloretin inhibits cellular uptake and nuclear receptor binding of triiodothyronine in human hep G2 hepatocarcinoma cells.
    Movius EG, Phyillaier MM, Robbins J.
    Endocrinology; 1989 Apr 20; 124(4):1988-97. PubMed ID: 2538319
    [Abstract] [Full Text] [Related]

  • 9. Thyroid hormone effect on alpha-fetoprotein and albumin coordinate expression by a human hepatoma cell line.
    Conti R, Ceccarini C, Tecce MF.
    Biochim Biophys Acta; 1989 Aug 14; 1008(3):315-21. PubMed ID: 2474323
    [Abstract] [Full Text] [Related]

  • 10. Thyroid hormone inhibits fibronectin synthesis by cultured human skin fibroblasts.
    Murata Y, Ceccarelli P, Refetoff S, Horwitz AL, Matsui N.
    J Clin Endocrinol Metab; 1987 Feb 14; 64(2):334-9. PubMed ID: 3793852
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of 23 K acute-phase protein by HBV genome carrying PLC/PRF/5 human hepatoma cells.
    Hájnická V, Fuchsberger N, Stancek D, Volná A, Cervenáková L.
    Acta Virol; 1992 Dec 14; 36(6):581-4. PubMed ID: 1284869
    [Abstract] [Full Text] [Related]

  • 12. Modulation of T3-induced sex hormone-binding globulin secretion by human hepatoblastoma cells.
    Payne KL, Loidl NM, Lim CF, Topliss DJ, Stockigt JR, Barlow JW.
    Eur J Endocrinol; 1997 Oct 14; 137(4):415-20. PubMed ID: 9368511
    [Abstract] [Full Text] [Related]

  • 13. Effect of estrogen on the synthesis and secretion of thyroxine-binding globulin by a human hepatoma cell line, Hep G2.
    Ain KB, Refetoff S, Sarne DH, Murata Y.
    Mol Endocrinol; 1988 Apr 14; 2(4):313-23. PubMed ID: 2837662
    [Abstract] [Full Text] [Related]

  • 14. Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apo B100 by the human hepatoma cell line Hep G2. Induction of apo A-I mRNA with no change of apo B100 mRNA.
    Kaptein A, Roodenburg L, Princen HM.
    Biochem J; 1991 Sep 01; 278 ( Pt 2)(Pt 2):557-64. PubMed ID: 1654887
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor beta 1 regulates production of acute-phase proteins.
    Mackiewicz A, Ganapathi MK, Schultz D, Brabenec A, Weinstein J, Kelley MF, Kushner I.
    Proc Natl Acad Sci U S A; 1990 Feb 01; 87(4):1491-5. PubMed ID: 1689487
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines.
    Saito H, Goodnough LT, Knowles BB, Aden DP.
    Proc Natl Acad Sci U S A; 1982 Sep 01; 79(18):5684-7. PubMed ID: 6291058
    [Abstract] [Full Text] [Related]

  • 17. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2).
    Arrol S, Mackness MI, Durrington PN.
    Atherosclerosis; 2000 Jun 01; 150(2):255-64. PubMed ID: 10856517
    [Abstract] [Full Text] [Related]

  • 18. The differentiation-inducing agent sodium butyrate produces divergent effects on albumin and thyroxine-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells.
    Bartalena L, Bogazzi F, Donadel G, Martino E, Gabrielli F, Pinchera A.
    J Endocrinol Invest; 1990 Dec 01; 13(11):917-22. PubMed ID: 1965315
    [Abstract] [Full Text] [Related]

  • 19. The production of heparin cofactor II is not regulated by inflammatory cytokines in human hepatoma cells: comparison with plasminogen activator inhibitor type-1.
    Koike C, Hayakawa Y, Niiya K, Sakuragawa N, Sasaki H.
    Thromb Haemost; 1996 Feb 01; 75(2):298-302. PubMed ID: 8815580
    [Abstract] [Full Text] [Related]

  • 20. L-Triiodothyronine (T3) stimulates growth of cultured GC cells by action early in the G1 period: evidence for mediation by the nuclear T3 receptor.
    DeFesi CR, Fels EC, Surks MI.
    Endocrinology; 1985 May 01; 116(5):2062-9. PubMed ID: 2985370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.